Department of Surgery-Traumatology, Leiden University Medical Centre, Leiden, The Netherlands.
Br J Surg. 2012 Apr;99(4):506-13. doi: 10.1002/bjs.7744. Epub 2011 Dec 2.
No consensus exists as to whether antibiotic prophylaxis in tube thoracostomy as primary treatment for traumatic chest injuries reduces the incidence of surgical-site and pleural cavity infections.
A systematic literature search was performed according to PRISMA guidelines to identify randomized clinical trials on antibiotic prophylaxis in tube thoracostomy for traumatic chest injuries. Data were extracted by two reviewers using piloted forms. Mantel-Haenszel pooled odds ratios (ORs) were calculated with 95 per cent confidence intervals (c.i.).
Eleven articles were included, encompassing 1241 chest drains in 1234 patients. Most patients (84·7 per cent) were men, and a penetrating injury mechanism was most common (856, 69·4 per cent). A favourable effect of antibiotic prophylaxis on the incidence of pulmonary infection was found, with an OR for the overall infectious complication rate of 0·24 (95 per cent c.i. 0·12 to 0·49). Patients who received antibiotic prophylaxis had an almost three times lower risk of empyema than those who did not receive antibiotic treatment (OR 0·32, 0·17 to 0·61). A subgroup analysis in patients with penetrating chest injuries showed that antibiotic prophylaxis in these patients reduced the risk of infection after tube thoracostomy (OR 0·28, 0·14 to 0·57), whereas in a relatively small blunt trauma subgroup no effect of antibiotic prophylaxis after blunt thoracic injury was found.
Infectious complications are less likely to develop when antibiotic prophylaxis is administered to patients with thoracic injuries requiring chest drains after penetrating injury.
对于创伤性胸部损伤,作为主要治疗方法的胸腔引流管预防性使用抗生素是否能降低手术部位和胸腔感染的发生率,目前尚无共识。
根据 PRISMA 指南进行系统文献检索,以确定关于创伤性胸部损伤中胸腔引流管预防性使用抗生素的随机临床试验。两位评审员使用预试验表格提取数据。采用 Mantel-Haenszel 汇总比值比(OR)及其 95%置信区间(CI)。
共纳入 11 篇文章,包括 1234 例患者的 1241 根胸腔引流管。大多数患者(84.7%)为男性,最常见的损伤机制为穿透伤(856 例,69.4%)。预防性使用抗生素可降低肺部感染的发生率,总感染并发症发生率的 OR 为 0.24(95%CI 0.12 至 0.49)。与未接受抗生素治疗的患者相比,接受抗生素预防的患者发生脓胸的风险几乎降低了三倍(OR 0.32,0.17 至 0.61)。对穿透性胸部损伤患者的亚组分析显示,这些患者接受抗生素预防可降低胸腔引流后感染的风险(OR 0.28,0.14 至 0.57),而在相对较小的钝性胸部损伤亚组中,未发现钝性胸部损伤后使用抗生素预防的效果。
对于穿透性胸部损伤需要胸腔引流的患者,预防性使用抗生素可降低感染性并发症的发生风险。